The Gross Margin of Neovacs SA (ALNEV.PA) is -11.20%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | -11.20% |
| 2023-12-31 | 5.49% |
| 2022-12-31 | -51918.92% |
| 2021-12-31 | -2051.29% |
| 2020-12-31 | -302.95% |
| 2019-12-31 | -94950.87% |
| 2018-12-31 | -6539.58% |